# DefEYE Closes $12M Series Seed with Celularity and ExSight Ventures

> financing · REPORTED · 2025-11-06

DefEYE, Inc. closed a $12 million Series Seed Preferred Equity round with in-kind investment from Celularity and a follow-on investment from ExSight Ventures, funding commercialization of its decellularized placental-based ophthalmic biologics portfolio.

- Company: DefEYE
- Sector: medical devices
- Primary source: https://www.businesswire.com/news/home/20251106137729/en/DefEYE-Inc.-Announces-Investment-from-ExSight-Ventures

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.